查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401872

到 2030 年神经生理学器材和设备的全球市场预测：按模式、技术、应用、最终用户和地区进行分析

Neurophysiology Devices and Equipment Market Forecasts to 2030 - Global Analysis By Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球神经生理学仪器和设备市场规模为15.2亿美元，预计到2030年将达到29.5亿美元，预测期内复合年增长率为9.9%。

神经生理学设备和仪器是一大类医疗设备和工具，旨在测量、监测、刺激和记录神经系统内的电活动和反应。这些设备用于各种临床、研究和诊断应用，以评估和了解大脑、脊髓、神经和肌肉的功能。

据美国国家脑肿瘤协会称，到 2021 年，美国将有大约 83,570 人患有脑肿瘤。

神经系统疾病盛行率上升

全球癫痫、阿兹海默症、阿兹海默症和中风等神经系统疾病的盛行率不断上升，增加了对先进诊断和监测设备的需求。神经生理学设备对于及时识别、准确诊断和持续监测各种状况至关重要。这些设备使医疗保健专业人员能够评估神经反应、肌肉功能和大脑活动，有助于做出准确的诊断和个人化治疗计划。此外，神经系统疾病的盛行率不断增加，需要有效且可靠的神经生理学设备来改善患者管理。这正在推动产业研究、创新和开发最尖端科技，以满足医疗保健中神经系统疾病不断增长的需求。

高成本

先进的神经生理学设备，例如脑电图、脑磁图和肌电图系统，通常需要大量的初始投资，以及持续的维护、升级和培训成本。这些高昂的成本限制了小型诊所、预算有限的医疗机构或资源有限的地区获得最先进的设备。医疗保健工作者操作这些设备和解释资料的专门培训成本进一步加剧了财务负担。因此，对市场拓展的需求正在减少。

整合人工智慧和资料分析

人工智慧主导的演算法和资料分析可以对脑电图、脑磁图和肌电图系统等设备捕获的复杂神经讯号进行高阶处理、解释和提取有意义的见解。人工智慧演算法促进模式识别、异常检测和预测建模，以提高神经系统疾病诊断、追踪和治疗计划的准确性。此外，这种整合将增加神经生理学设备的力量和价值，促进创新，并为更有效的资料处理、即时回馈和更好的决策提供机会，以改善临床神经病学和神经科学。

复杂性和培训

先进的神经生理学仪器和设备，如脑电图和脑磁图系统的操作很复杂，需要专门的训练才能有效使用。解释复杂的神经讯号需要专业知识，而缺乏熟练处理这些设备的专家是一个挑战。需要全面的培训计划以及对医疗保健负责人进行有关这些复杂技术的教育的时间投入可能会成为障碍，限制临床实践中的普及和最佳使用，从而阻碍市场成长。

COVID-19 的影响

COVID-19 的爆发对神经生理学设备和设备市场产生了多方面的影响。在大流行的早期阶段，由于资源重新分配、门诊量减少和择期手术取消，医院和诊所在提供常规护理方面面临限制。全球医疗保健系统的经济景气衰退和预算限制影响了资本支出，可能会减缓对新神经生理学设备的投资。这导致用于非紧急情况的神经生理学设备的引进暂时减少。儘管面临挑战，这场流行病加速了远端技术的创新，并促进了用户友好且可远端存取的神经生理学设备和软体的开发。

脑电图（EEG）领域预计将在预测期内达到最大

脑电图（EEG）领域估计占据最大占有率。脑电图 (EEG) 是一种使用放置在头皮上的小金属盘（电极）来测量大脑电活动的测试。脑电图机捕捉脑波模式，可以帮助诊断各种神经系统疾病，包括癫痫、睡眠障碍和脑损伤。脑电图技术的进步导致了便携式、无线、高解析度系统的出现，可实现即时监测和分析。脑电图在临床神经病学、神经回馈治疗和研究中发挥着重要作用，推动了神经生理学设备市场的持续创新和普及。

医院部门预计在预测期内复合年增长率最高

预计医院业务在预测期内将出现良好成长。医院在神经科、加护病房(ICU) 和神经外科等科室使用各种神经生理学设备进行诊断、监测和治疗。在医院，神经生理学设备有助于诊断癫痫、中风、脑肿瘤和神经肌肉疾病。这些设备包括脑电图 (EEG)、肌电图 (EMG)、脑磁图 (MEG) 以及 MRI 和 CT 扫描仪等神经影像系统。在医院领域，对准确性、可靠性和创新功能的重视，以改善神经评估和治疗中的患者照护和临床结果，正在推动对先进神经生理学设备的需求。

占有率最大的地区

由于医疗保健支出增加、神经系统疾病盛行率上升以及医疗保健基础设施的进步，亚太地区在预测期内占据了最大的市场占有率。中国、印度、日本和韩国等国家的大量患者和不断增加的医疗保健投资在这一扩张中发挥关键作用。此外，亚太地区由于与国际製造商的合作伙伴关係以及对研发的重视，为神经生理学设备和设备市场的扩大做出了重大贡献。

复合年增长率最高的地区：

由于强大的医疗基础设施和技术进步，预计北美在预测期内将实现盈利增长。该地区建立了研究和医疗机构，促进了技术创新和先进神经生理学设备的采用。在美国和加拿大等国家，用于诊断神经系统疾病的脑电图、肌电图和神经影像设备的需求很高。此外，神经系统疾病的日益普及、人口高龄化以及对个人化医疗的重视，都有助于该地区在北美神经生理学技术的采用和市场扩张方面处于领先地位。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球神经生理学设备和设备市场：按方式

  • 便携的
  • 独立的

第六章全球神经生理学设备与设备市场：依技术分类

  • 肌电图（EMG）
  • 皮质电图（ECoG）
  • 脑电图（EEG）
  • 诱发电位 (EP)
  • 其他技术

第七章全球神经生理学设备和设备市场：按应用

  • 睡眠失调
  • 帕金森氏症
  • 癫痫
  • 阿兹海默症
  • 其他用途

第八章全球神经生理学设备和设备市场：按最终用户分类

  • 门诊手术中心
  • 医院
  • 其他最终用户

第九章全球神经生理学设备和设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Medtronic PLC.
  • Dr. Langer Medical Gmbh
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • NuVasiveInc.
  • Inomed Medizintechnik
  • Axon Healthcare Ltd.
  • Neurosign
  • Bovie Medical Corporation
  • Neurowave Systems
  • Koninklijke Philips NV
  • Cadwell Industries, Inc.
  • Electrical Geodesics Incorporated
  • Advanced Brain Monitoring, Inc.
Product Code: SMRC24392

According to Stratistics MRC, the Global Neurophysiology Devices and Equipment Market is accounted for $1.52 billion in 2023 and is expected to reach $2.95 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Neurophysiology devices and equipment are a broad category of medical instruments and tools designed to measure, monitor, stimulate, or record the electrical activity and responses within the nervous system. These devices are utilised in various clinical, research, and diagnostic applications to assess and understand the functioning of the brain, spinal cord, nerves, and muscles.

According to the National Brain Tumour Society, approximately 83,570 persons in the United States will be affected by Brain Tumours in 2021.

Market Dynamics:

Driver:

Rising prevalence of neurological disorders

The increasing prevalence of neurological disorders such as epilepsy, Parkinson's, Alzheimer's, and stroke worldwide has led to a greater need for sophisticated diagnostic instruments and monitoring apparatus. Neurophysiology equipment is essential for the timely identification, precise diagnosis, and ongoing surveillance of various conditions. They make it possible for medical practitioners to evaluate neural responses, muscle function, and brain activity, which helps with accurate diagnosis and individualised treatment plans. Moreover, the growing prevalence of neurological diseases makes effective and dependable neurophysiology devices necessary for improved patient management. This is propelling the industry's research, innovation, and development of cutting-edge technologies to meet the expanding demands of neurological conditions in healthcare.

Restraint:

High cost

Advanced neurophysiology devices, such as EEG, MEG, and EMG systems, often require substantial initial investments, coupled with ongoing expenses for maintenance, upgrades, and training. These elevated costs limit access to state-of-the-art equipment for smaller clinics, healthcare facilities with limited budgets, or regions with constrained resources. Also, the expense of specialised training for healthcare professionals to operate and interpret data from these devices further adds to the financial burden. Thus, there is a decreasing demand for market expansion.

Opportunity:

Integration of AI and data analytics

AI-driven algorithms and data analytics enable advanced processing, interpretation, and extraction of meaningful insights from complex neural signals captured by devices like EEG, MEG, and EMG systems. Pattern identification, anomaly detection, and predictive modelling are made easier by AI algorithms, which improve the precision of neurological disease diagnosis, tracking, and treatment planning. Moreover, this integration enhances the capabilities and value of neurophysiology equipment, promotes innovation, and enhances clinical neurology and neuroscience by providing opportunities for more effective data processing, real-time feedback, and better decision-making.

Threat:

Complexity and training

The complexity of operating sophisticated neurophysiology devices and equipment, such as EEG or MEG systems, requires specialised training for effective use. Interpretation of complex neural signals demands expertise, posing a challenge due to a shortage of skilled professionals proficient in handling these devices. The need for comprehensive training programmes and the time investment to educate healthcare personnel about these intricate technologies create a barrier, potentially limiting their widespread adoption and optimal utilisation in clinical settings, thereby hindering market growth.

COVID-19 Impact

The COVID-19 pandemic has had a multifaceted impact on the neurophysiology devices and equipment market. During the initial phases of the pandemic, hospitals and clinics faced constraints in providing routine care due to resource reallocation, reduced outpatient visits, and elective procedure cancellations. Economic downturns and budget constraints in healthcare systems globally affected capital expenditure, potentially slowing down investments in new neurophysiology equipment. This led to a temporary decline in the adoption of neurophysiology devices for non-urgent cases. Despite challenges, the pandemic accelerated innovation in remote technologies, fostering the development of user-friendly, remote-accessible neurophysiology devices and software.

The Electroencephalography (EEG) segment is expected to be the largest during the forecast period

The Electroencephalography (EEG) segment is estimated to hold the largest share. An electroencephalogram (EEG) is a test that measures electrical activity in the brain using small metal discs (electrodes) attached to the scalp. EEG devices capture brainwave patterns, aiding in the diagnosis of various neurological conditions such as epilepsy, sleep disorders, and brain injuries. Advancements in EEG technology have led to portable, wireless, and high-resolution systems, enabling real-time monitoring and analysis. EEG plays a crucial role in clinical neurology, neurofeedback therapies, and research, driving continuous innovation and adoption in the market for neurophysiology devices.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals utilise various neurophysiology devices for diagnostics, monitoring, and treatment purposes in neurology departments, intensive care units (ICUs), and neurosurgery units. In hospitals, neurophysiology equipment aids in diagnosing epilepsy, stroke, brain tumours, and neuromuscular disorders. These devices include electroencephalography (EEG), electromyography (EMG), magnetoencephalography (MEG), and neuroimaging systems like MRI and CT scanners. The hospital segment drives significant demand for advanced neurophysiology equipment, emphasising accuracy, reliability, and innovative features to enhance patient care and clinical outcomes in neurological assessments and treatments.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to increasing healthcare expenditure, the rising prevalence of neurological disorders, and advancements in healthcare infrastructure. The significant patient populations and increasing healthcare investments in nations like China, India, Japan, and South Korea play a crucial role in this expansion. Additionally, the Asia-Pacific area makes a substantial contribution to the growing market for neurophysiology devices and equipment due to partnerships with international manufacturers and a focus on research and development.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to robust healthcare infrastructure and technological advancements. The regions well-established research facilities and healthcare institutions fuel innovation and the adoption of advanced neurophysiology devices. Countries like the United States and Canada witness substantial demand for EEG, EMG, and neuroimaging equipment for diagnosing neurological disorders. Moreover, the increasing prevalence of neurological conditions, ageing population, and emphasis on personalised medicine contribute to the region's leadership in neurophysiology technology adoption and market expansion in North America.

Key players in the market:

Some of the key players in the Neurophysiology Devices and Equipment Market include Medtronic PLC., Dr. Langer Medical Gmbh, Nihon Kohden Corporation, Natus Medical Incorporated, NuVasiveInc., Inomed Medizintechnik, Axon Healthcare Ltd., Neurosign, Bovie Medical Corporation, Neurowave Systems, Koninklijke Philips N.V., Cadwell Industries, Inc., Electrical Geodesics Incorporated, and Advanced Brain Monitoring, Inc.

Key Developments:

In December 2022, Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions. Exciting combination of product solutions will create a leading neurodiagnostic and neuromonitoring portfolio supported by an organization of knowledgeable and passionate experts.

In October 2022, Nihon Kohden, a U.S. market leader in precision medical products and services, announced the launch of the Smart Cable™ NMT Pod and disposable electrode, allowing clinicians to monitor neuromuscular blockade with confidence. The new device allows clinicians to objectively monitor the patient's depth of paralysis during surgery when a neuromuscular blockade agent (NMBA), either non-depolarizing or depolarizing, is administered to the patient.

Modalities Covered:

  • Portable
  • Standalone

Technologies Covered:

  • Electromyography (EMG)
  • Electrocorticography (ECoG)
  • Electroencephalography (EEG)
  • Evoked potential (EP)
  • Other Technologies

Applications Covered:

  • Sleep Disorders
  • Parkinson's Disease
  • Epilepsy
  • Alzheimer's Disease
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurophysiology Devices and Equipment Market, By Modality

  • 5.1 Introduction
  • 5.2 Portable
  • 5.3 Standalone

6 Global Neurophysiology Devices and Equipment Market, By Technology

  • 6.1 Introduction
  • 6.2 Electromyography (EMG)
  • 6.3 Electrocorticography (ECoG)
  • 6.4 Electroencephalography (EEG)
  • 6.5 Evoked potential (EP)
  • 6.6 Other Technologies

7 Global Neurophysiology Devices and Equipment Market, By Application

  • 7.1 Introduction
  • 7.2 Sleep Disorders
  • 7.3 Parkinson's Disease
  • 7.4 Epilepsy
  • 7.5 Alzheimer's Disease
  • 7.6 Other Applications

8 Global Neurophysiology Devices and Equipment Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Neurophysiology Devices and Equipment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic PLC.
  • 11.2 Dr. Langer Medical Gmbh
  • 11.3 Nihon Kohden Corporation
  • 11.4 Natus Medical Incorporated
  • 11.5 NuVasiveInc.
  • 11.6 Inomed Medizintechnik
  • 11.7 Axon Healthcare Ltd.
  • 11.8 Neurosign
  • 11.9 Bovie Medical Corporation
  • 11.10 Neurowave Systems
  • 11.11 Koninklijke Philips N.V.
  • 11.12 Cadwell Industries, Inc.
  • 11.13 Electrical Geodesics Incorporated
  • 11.14 Advanced Brain Monitoring, Inc.

List of Tables

  • Table 1 Global Neurophysiology Devices and Equipment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 3 Global Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 4 Global Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 5 Global Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 6 Global Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 7 Global Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 8 Global Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 9 Global Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 10 Global Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 13 Global Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 14 Global Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 15 Global Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 16 Global Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 19 Global Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 20 Global Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 23 North America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 24 North America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 25 North America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 26 North America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 27 North America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 28 North America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 29 North America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 30 North America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 31 North America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 North America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 33 North America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 34 North America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 35 North America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 36 North America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 North America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 North America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 39 North America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 40 North America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 43 Europe Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 44 Europe Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 45 Europe Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 46 Europe Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 47 Europe Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 48 Europe Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 49 Europe Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 50 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 51 Europe Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 52 Europe Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 53 Europe Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 54 Europe Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 55 Europe Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 56 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 Europe Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Europe Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 59 Europe Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 Europe Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 63 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 64 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 65 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 66 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 67 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 68 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 69 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 70 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 71 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 72 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 73 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 74 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 75 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 76 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 77 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 78 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 79 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 80 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 83 South America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 84 South America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 85 South America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 86 South America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 87 South America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 88 South America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 89 South America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 90 South America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 91 South America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 92 South America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 93 South America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 94 South America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 95 South America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 96 South America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 South America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 South America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 99 South America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 100 South America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 103 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 104 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 105 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 106 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 107 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 108 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 109 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 110 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 111 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 112 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 113 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 114 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 115 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 116 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 117 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 118 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 119 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 120 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)